China's Sinovac gets funding to boost production of Covid-19 vaccine

China's Sinovac gets funding to boost production of Covid-19 vaccine

Turkish Health Minister Fahrettin Koca earlier announced that the country had signed a contract to buy 50 million doses of the COVID-19 vaccine from Sinovac Biotech. About 800,000 doses are expected to be available within the first week. The vaccination campaign will kickstart in India as soon as a vaccine is approved by the scientists.

The first phase of the COVID-19 vaccination would be prioritized for health workers, health worker assistants, and supporting workers in health facilities, Antara news agency quoted him as saying.

The presentation was given by Union Health Secretary Rajesh Bhushan at the meeting, which was chaired by Prime Minister Narendra Modi.

The Chief Minister said while it appeared that private sector healthcare workers would be enumerated and that the Centre also intends to provide vaccines for them, apart from government sector healthcare workers, the question did arise if the vaccines also be provided to other priority groups and the general population, should they wish to receive vaccines from government providers.

CoronaVac is one of three experimental COVID-19 vaccines China has been using to inoculate around one million people under an emergency-use programme. Capt. SIngh added that as of now, it seemed to include only security forces (the police and armed forces) and municipal workers, with some mention of primary school teachers.

The CM also sought expansion of the definition of frontline workers for the objective of immunisation to include administrative officials and others responsible for essential functions.

Political parties that participated in the meeting included the Indian National Congress, Trinamool Congress, DMK, YSR Congress Party, JD (U), BJD, Shiv Sena, TRS, BSP, SP, AIADMK and BJP.

Indonesia is already cooperating with Sinovac in phase 3 clinical trials of its vaccine candidate, with tests being carried out on 1,620 volunteers in West Java's Bandung city since August.

Now in India, Pune-based Serum Institute of India has said that it will apply for emergency use licensure for AstraZeneca-Oxford vaccine in two weeks.

However, he also reminded people about following COVID-19 norms until a vaccine is not made.

Related Articles